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Abstract: Mucopolysaccharidosis IIID (MPS IIID) or Sanfilippo D syndrome is an inherited lysosomal storage disease and caused by a
deficiency of the N-acetylglucosamine-6-sulfatase activity, which involves in the catabolism of heparan sulfate. In addition to humans,
canine, feline and murine, goats have been reported as possessing this lysosomal storage disease. The molecular defect in the MPS IIID
goat has been previously identified. It has been observed that a molecular base for this defect is a nonsense mutation at nucleotide 322
(C→T) results in the change of the arginine codon to a stop codon. This mutation is not only to be related to stop enzyme function but
also introduces a recognition site for AluI that will enable carrier detection. The goal of this study is to find the presence of MPS IIID
genetic disorder in some goat breeds. A total of 80 goat blood samples selected randomly from 4 different countries including Kyrgyzstan,
Iraq, Northern Cyprus and Bosnia-Herzegovina were used as a sample. Polymerase chain reaction (PCR)-restriction fragment length
polymorphism (RFLP) and DNA sequence data were utilized to identify this disorder in the goat populations. The result of this study
demonstrates nonsense mutation which causes MPS IIID genetic disorder was not found in the goat breeds studied, while a silent
mutation was found at nucleotide 354 (T→C) when compared with reference sequence.
Key words: Goat, genetic disorder, MPS IIID

1. Introduction
The mucopolysaccharidoses (MPS) are heritable
lysosomal storage diseases (LSD) where the functional
deficiency of any 1 of 11 lysosomal enzymes needed to
degrade glycosaminoglycans (GAGs), formerly referred
to as mucopolysaccharides [1–3]. Depending on the
deficiency of the activity in any of these enzymes disrupts
the degradation of GAGs and results in an accumulation of
GAGs in lysosomes. As a result, lysosomal accumulation
of GAGs leads to cell, tissue, and organ dysfunction
[4–6]. One group of these diseases are known as a
mucopolysaccharidosis type III (MPS III) or Sanfilippo
syndrome. MPS III is an autosomal recessive disorder
including four subtypes (A-D). Each is due to lack of one
of four lysosomal enzymes that participate in the removal
of sulfated N-acetylglucosamine residues during the
degradation of heparan sulfate (HS) [2,7]. Models for four
of the human MPS have been described and one of these
models is caprine N-acetylglucosamine 6-sulfatase (GNS)
deficiency represents the only animal analog of MPS IIID
[8]. Caprine MPS IIID is an inherited lysosomal storage
disease (LSD) caused by a lack in N-acetylglucosamine
6-sulfatase. In caprine MPS IIID, the GNS deficiency
consequent to a single nonsense mutation [9]. Biochemical

and immunohistochemical characterization of caprine
MPS IIID has been reported and analyses showed increased
accumulation of HS and free N-acetylglucosamine sulfate
in central nervous system and somatic tissues [4,8].
Among affected goats, phenotypic variation in MPS IIID
disease expression with mild and serious forms has been
reported. However similar to human phenotype, the
affected goat demonstrated delayed motor development,
growth retardation, and accumulation of gangliosides in
the central nervous system [10]. Caprine GNS’s cDNA has
been cloned and sequenced by Friderici et al. [9] and the
cDNA defect in caprine MPS IIID has been detected by
Cavanagh et al. [11]. A mutation test utilizing PCR has
been introduced to carrier identification and prenatal
testing for the disorder in goats [12]. The molecular base
for this disorder was due to a nonsense C→T mutation in
codon 102 from GNS cDNA of the affected animal. This
mutation not only truncating the protein but also creates
an AluI restriction site, which make possible carrier or
affected animal detection by RFLP. Caprine MPS IIID is
only identified in Nubian goats and their crosses. The goal
of this study is to find the presence of MPS IIID genetic
disorder in some goat breeds from different countries. It
is thought that the information obtained as a result of this
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research will contribute to both goat genetic information
and human health studies as well.
2. Materials and methods
2.1. Collection of sample and DNA extraction
In this study, blood samples originated from goats
were obtained from four different sampling countries:
Kyrgyzstan, Iraq, Northern Cyprus and Bosnia-Herzegovina. A total of 80 samples are selected randomly
from different goat breeds grown in universities and
private companies in various cities of these countries.
Information about the samples analyzed in the study
was shown in Table. Goat blood samples were collected
by puncture of jugular vein into sterile tubes containing
EDTA. Total genomic DNA was extracted from blood
samples by standard salting-out extraction method [13].
The quality and quantity of extracted DNA was checked
on 1% agarose gel electrophoresis and spectrophotometer
at A260/A280 nm, respectively.
2.2. Polymerase chain reaction and enzyme digestion
The primers used for amplification of the GNS gene
including mutation site MPS IIID were reported by
Leipprandt et al. [12] with the following forward (F) and
reverse (R) nucleotide sequences; F: 5′-CTT ATG TGC
CAA GTG CTC TC-3′ and MPS IIID- R: 5′-CCT CCA
GAG TGT TGT TAA CC-3′. PCR amplifications were
conducted in 25 μL with 1 µL of genomic DNA (100 ng/
µL), 200 µM each dNTP, 0.10 µM of each primer and 1.25
U Taq DNA polymerase (Fermentas EP0401). Reactions
were performed in a thermal cycler (BioRad MyCycler)
with the following conditions: 94 °C for 7 min followed
by 35 thermal cycles of 30 s at 94 °C, 30 s at 55 °C, 30
s at 72 °C and final extension at 72 °C for 10 min. After
the reactions, PCR products were digested with AluI
(Fermentas® ER0011) at 37 °C for at least 2 h and were
subjected to electrophoresis on 2% agarose gel stained
with ethidium bromide at 100 V for approximately 1.5 h.
Visualization of bands was carried out under ultraviolet
transillumination (Kodak Gel Logic 200) and the size of
the amplified fragments was compared with the 50 bp
DNA ladder (Fermentas GeneRuler SM0371).
2.3. DNA sequencing
The PCR products were sequenced using a BigDye
Terminator v3.1 cycle sequencing kit and an ABI PRISM
3130 automatic sequencer (Applied Biosystems, Foster City,
USA). Amplification primers were used for sequencing,
and each fragment was sequenced in both directions. Raw
sequencing data were visualized in FinchTv Version 1.4.0
as chromatograms. Sequences were aligned by using the
ClustalW method, a component of the program MEGA
6.0 [14] and then saved as a MEGA alignment file. DNA
sequencing results of 80 samples were aligned to C. hircus
GNS gene reference sequence (U17694.1).

Table. Sampling abbreviation and sample size (n) of goat breeds.
Breed

Abbreviation

n

Kyrgyzstan Angora

AGR

10

Kyrgyzstan Native

KRGY

15

Kyrgyzstan Cashmere

KSMR

10

Iraq Shami

SM-I

10

Iraq Hair

KIL-I

10

Cyprus Native

KBRY

15

Bosnia Native

BSNY

10

Total

80

3. Results and discussion
A 96-bp fragment containing the mutation site of GNS
gene that causing MPS IIID genetic disorder was produced.
These PCR products were subsequently digested with the
restriction enzyme AluI and separated on a 2% agarose
gel electrophoresis. Since the mutation creates an AluI
recognition site, the affected animals’ amplicons are cut to
66 bp. Normal animals contains no site for AluI that will
have only the 96-bp band, and carrier animals will have
96-bp, 66-bp, and 30-bp band. After digestion with AluI,
all samples showed a negative result for the nonsense
mutation at nucleotide 322 (C→T) of GNS gene (Figure 1).
DNA sequencing results also indicated no mutation at
this site. As a comparison with the reference sequence, it
was determined that all the samples got same substitutions
at nucleotide 354 a T changed to C (c.354T>C). This
substitution is a silent mutation, which determined in the
cDNA of all animals, changing a T to C in codon 112 of the
559 amino acid GNS coding sequence (Figure 2).
After the describing, a naturally occurring caprine
MPS IIID genetic disorder in Nubian goats, the caprine
GNS’s cDNA was cloned and sequenced, and the mutation
causing the defect was determined. Finally, the PCR-based
test was described and subsequently the observed genotypic
frequency for this defect was reported to be 25.2% carrier
and 1.3% affected Nubian goats [15]. Unfortunately, there
are very few studies to determine this genetic defect in
goat breeds. A total of 39 purebred Anglo Nubian goats
and 82 crossbred Anglo Nubian × Thai Native goats were
tested by RFLP and then 5 DNA samples were sequenced
by Wasiksiri et al. [16]. RFLP results in this study showed
no mutation at nucleotide 322; however, sequenced data
indicated polymorphism of base C at nucleotide 354. The
researcher attributed the absence of the mutation causing
the disorder to insufficient sample size and elimination of
the affected goats. Gedik and Kavuncu [17] investigated
the presence of MPS IIID genetic defect in Turkish native
goat breeds (total 120 sample from 13 different breed) by
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Figure 1. PCR-RFLP results of seven samples. N; negative control with no DNA, M; 50 bp DNA ladder. PCR-RFLP:
Polymerase chain reaction-restriction fragment length polymorphism, DNA: Deoxyribonucleic acid, bp: base pairs,
AGR: Kyrgyzstan Angora, KRGY: Kyrgyzstan Native, KSMR: Kyrgyzstan Cashmere, SM-I: Iraq Shami, KIL-I: Iraq Hair,
KBRY: Cyprus Native, BSNY: Bosnia Native.

Figure 2. Alignment of goat GNS gene with reference sequence (Ref. Seq U17694.1). GNS: N-acetylglucosamine
6-sulfatase gene, AGR: Kyrgyzstan Angora, KRGY: Kyrgyzstan Native, KSMR: Kyrgyzstan Cashmere, SM-I: Iraq
Shami, KIL-I: Iraq Hair, KBRY: Cyprus Native, BSNY: Bosnia Native, A: Adenine, C: Cytosine, G: Guanine, T:
Thymine.

PCR-RFLP and DNA sequencing. The results showed that
Turkish native goat breeds had no mutation that causes
disorder. As a result of sequencing, all sample were found
to be polymorphic at nucleotide 354. In this study, similar
results were found as in the previous two studies. While
the c.322 C>T mutation was not found, the c.354T>C
silent mutation was found. The first domesticated farm
animals were goats and they have been serving human
in many aspects for about 11,000 years. They have
socioeconomically high value and an important role in
feeding humans in many parts of the world especially in
the rural areas and developing countries. Because of their
high adaptability to extreme conditions and different
diets, they are always thought as very useful animals for
their good productivity. While goats are very important
and valuable animal, they are the least studied species
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amongst the ruminants. According to the OMIA (Online
Mendelian Inheritance in Animals), the database of genes
containing inherited disorders and traits, the number of
recorded disorder or traits which key mutation known are
only 14 in goats. These records for cattle (284) are nearly
twenty times and for sheep (54) about four times higher
than goats. MPS IIID is an inherited LSD first identified
in human and then found in Nubian goats. In human
medicine, Nubian goats have been used as a model to study
human diseases. Although various tissues are affected,
lysosomal accumulation of GAGs in the central nervous
system is generally responsible for main clinical symptoms
observed in human and goats. The main symptom in
affected goats is failure to grow. Goats with this disorder
are smaller than normal at birth and grow slowly. Some
of them grow as normal for the first three months and
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after that stopped growing. This growth retardation can
be confused with numerous nutritional, infectious, and
parasitic problems. Some affected goats lack muscle mass,
appear slab-sided, sometimes with blocky heads and may
have a compromised immune system. Sometimes they
become deaf or blind. Although affected animals can grow
up to breed, they often experience reproduction difficulties.
While progressive neurological signs appear in adult goats,
research should be conducted to determine whether
there is any association with other diseases affecting the
central nervous system, such as scrapie. The data that
can be obtained as a result of research to be carried out
for this purpose would be useful both for animal breeding
and human health. Unfortunately, genetic disorders are
minor concern in animal production, but increase in the
frequency and amount of carrier animals of these alleles/
defects might cause important economic losses. Testing the
herd may help to prevent economic losses due to genetic
disorders. On the other hand, the study to be done in
this area will also provide useful information on genetic
diversity and bring fresh insights goat domestication and
their dispersal.
4. Conclusion
Goat that has long been considered the poor man’s cow is
probably the most well-adapted farm animal and distributed
globally. Currently, there are over 1 billion goats around the
world. Up to last ten years, goat gene variants determining

phenotypes mostly have been identified by candidate
gene approaches. With the start of goat genome project,
more goat causative variants are expected to detect. New
molecular technologies, genomic tools and databases help
to gene identification and genomic analysis to find harness
genetic variations. With sequencing of goat genome and
systems approaches to genetic evolution animal welfare
and production will develop in future. Caprine MPS IIID
studies have mainly been performed to examine human
diseases and goats are used as a model. Studies to identify
this disease in goat breeds are very few and inadequate.
This disease has been identified only in the Nubian goats
until now and only has been studied in Turkish native
goat breeds. This research is the first study to detect the
GNS gene mutation in some goat breeds originated from
different countries. Although there is no GNS mutation
was found, silent mutation was found at nucleotide 354. As
a recommendation, for detection of GNS mutation there is
a need to carry out further studies using more sample size
and other goat breeds. Moreover, further studies should be
done to investigate whether the silent mutation we have
found could be related to MPS IIID genetic disorder or
other traits/diseases. It is hoped that this research will lead
studies attempting to reveal genetic causes of MPS IIID and
other genetic disorders in goats.
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